Why this topic matters: Tubulointerstitial diseases injure the kidney tubules and surrounding interstitium. They may cause acute kidney injury, electrolyte and acid–base disorders, polyuria, impaired concentration, fever, rash or progressive chronic kidney disease. Acute interstitial nephritis is often medication-related and may be reversible when recognised early. Emergency providers must identify the trigger, stop avoidable exposure, assess dangerous complications and refer promptly.
Learning objectives
- Differentiate acute interstitial nephritis, acute tubular injury and chronic tubulointerstitial disease.
- Recognise AKI, electrolyte loss, acidosis, polyuria, obstruction and systemic red flags.
- Take a complete medication, infection, toxin, occupational and family history.
- Describe investigations, supportive care, medicine withdrawal and specialist treatment.
- Plan nursing monitoring, prevention, discharge education and renal follow-up.
Definition and pathophysiology
The renal tubules reabsorb water and electrolytes, regulate acid-base balance and concentrate urine. The interstitium contains supporting tissue, blood vessels and immune cells. Tubulointerstitial disease disrupts these functions without necessarily causing heavy proteinuria or dramatic urine findings.
Acute tubulointerstitial nephritis (ATIN) is commonly an immune-mediated reaction to a drug, infection or systemic disease. Acute tubular injury/necrosis follows ischaemia, sepsis, toxins or pigment injury. Chronic tubulointerstitial nephritis develops from prolonged medicines, obstruction, reflux, metabolic disease, toxins, autoimmune disease or inherited disorders and may progress to CKD.
Causes and risk settings
| Cause | Examples | Important clues |
|---|---|---|
| Medicines | Beta-lactam antibiotics, sulfonamides, NSAIDs, PPIs, diuretics, anticonvulsants, rifampicin and selected antivirals. | New medicine or dose change days to weeks before AKI, fever, rash or eosinophilia. |
| Ischaemia/sepsis | Shock, severe infection, burns, surgery or major blood loss. | Hypotension, lactate rise, oliguria and multi-organ dysfunction. |
| Toxins/pigment | Heavy metals, solvents, contrast, myoglobin and haemoglobin. | Occupational exposure, rhabdomyolysis, dark urine or haemolysis. |
| Infection/immune disease | Pyelonephritis, TB, HIV, sarcoidosis, lupus, Sjögren and vasculitis. | Fever, systemic symptoms, rash, pulmonary or joint disease. |
| Chronic structural/metabolic | Reflux, obstruction, stones, analgesic abuse, hypercalcaemia, hypokalaemia or cystic disease. | Polyuria, bland urine, concentrating defect and slowly falling eGFR. |
Emergency red flags
- Rapid creatinine rise, oliguria/anuria, hyperkalaemia, acidosis or pulmonary oedema.
- Fever, diffuse rash, facial swelling, wheeze or hypotension after a medicine.
- Severe polyuria with dehydration, hypernatremia or hypokalaemia.
- Confusion, seizures, pericarditis, bleeding or other uraemic complications.
- Sepsis, shock, rhabdomyolysis, haemolysis or suspected toxin exposure.
- Pregnancy, child, transplant, solitary kidney or advanced CKD with new deterioration.
Triage and first contact
- Place unstable patients in a monitored area; call senior emergency, renal, pharmacy and critical-care support.
- Ask about every prescribed, over-the-counter, herbal and traditional medicine; record start/stop dates and dose.
- Assess urine volume, thirst, nocturia, fever, rash, joint pain, infection, obstruction, workplace chemicals and recent contrast.
- Perform ABCDE, glucose, ECG, BP, fluid-status assessment, skin examination and medication reconciliation.
- Stop suspected non-essential nephrotoxins under prescriber guidance and arrange urgent renal referral for AKI or systemic disease.
ABCDE assessment
| Step | Assess | Actions |
|---|---|---|
| A – Airway | Uraemic vomiting, confusion, seizures and aspiration risk. | Position, suction and airway support if consciousness is impaired. |
| B – Breathing | Crackles, hypoxia, Kussmaul breathing, pulmonary oedema or haemoptysis. | Oxygen for hypoxaemia and urgent fluid/renal/critical-care review. |
| C – Circulation | BP, perfusion, dehydration, oedema, arrhythmia and shock. | Carefully reassessed fluids or source control; continuous ECG for electrolyte risk. |
| D – Disability | Glucose, confusion, asterixis, seizures, weakness and tetany. | Check electrolytes, treat emergencies and reassess after intervention. |
| E – Exposure | Rash, fever, oedema, bruising, muscle tenderness and catheter/obstruction signs. | Identify trigger, prevent pressure injury and preserve dignity. |
History and examination
- Timeline of renal decline, urine output, thirst, nocturia, weight change and previous kidney function.
- Medication history including antibiotics, NSAIDs, PPIs, diuretics, anticonvulsants, supplements and herbal remedies.
- Recent infections, fever, rash, joint pain, sinus disease, autoimmune symptoms, TB/HIV risk and travel.
- Shock, burns, surgery, trauma, contrast, muscle injury, strenuous exercise and heat exposure.
- Examine volume status, lungs, heart, BP, skin, joints, muscle tenderness, abdomen, bladder and neurological function.
Investigations
| Test | Purpose | Interpretation |
|---|---|---|
| Creatinine/eGFR, urea and electrolytes | Identify AKI, CKD, potassium and acid-base complications. | Trend results and adjust renally cleared medicines. |
| Urinalysis/microscopy | Detect blood, protein, leucocytes, casts and concentration defect. | WBCs or WBC casts may support interstitial inflammation; bland urine does not exclude disease. |
| FBC, eosinophils, CRP, cultures | Assess inflammation, infection and allergic reaction. | Eosinophilia is supportive but not required for ATIN. |
| CK, blood gas, glucose, calcium, phosphate and magnesium | Identify rhabdomyolysis, acidosis and electrolyte wasting. | Correct life-threatening abnormalities immediately. |
| Autoimmune, infection and toxin tests | Find systemic or exposure-related causes. | Use history to guide ANCA, ANA, complements, HIV/TB/hepatitis and toxicology. |
| Ultrasound/biopsy | Exclude obstruction and establish diagnosis when needed. | Biopsy is specialist-led after coagulation/BP review. |
Immediate management
- Stop the suspected offending medicine or toxin when safe and document the reaction in the medical record.
- Treat sepsis, shock, obstruction, rhabdomyolysis and other reversible causes promptly.
- Maintain euvolaemia; give fluid for true depletion and restrict/diurese clinically important overload under prescription.
- Correct hyperkalaemia, acidosis, severe sodium/potassium loss and glucose disturbances.
- Adjust all medicines for changing renal function and involve pharmacy/renal services.
- Discuss renal replacement therapy for refractory potassium/acidosis, pulmonary oedema, uraemia or dialysable toxins.
Acute interstitial nephritis
ATIN often develops after a medicine exposure and may present with AKI, fever, rash, arthralgia, eosinophilia, pyuria or mild proteinuria. The classic triad is not present in every patient. Treatment begins with stopping the trigger and managing complications. Corticosteroids may be considered for immune-mediated or selected medication-related cases by a nephrologist, often after biopsy or careful assessment.
- Review the medication timeline and identify the most likely culprit.
- Stop non-essential suspected medicines; substitute essential treatment with specialist advice.
- Monitor creatinine, urine output, potassium, BP, rash and systemic symptoms.
- Exclude infection and obstruction before immunosuppression.
- Arrange renal follow-up because recovery may be incomplete and CKD can develop.
Acute tubular injury and chronic disease
- In ischaemic or septic tubular injury, restore perfusion, control infection, avoid further nephrotoxins and maintain euvolaemia.
- Rhabdomyolysis requires early assessment of CK, potassium, calcium, acidosis and urine output, with carefully guided fluids.
- Chronic tubulointerstitial disease may cause polyuria, nocturia, salt wasting, metabolic acidosis and progressive CKD.
- Treat obstruction, metabolic causes, infection and occupational exposures; arrange nephrology follow-up and renal-dose medication review.
Electrolyte and acid-base emergencies
- Hyperkalaemia: ECG, cardiac membrane stabilisation and potassium-shifting/removal protocol.
- Hypokalaemia: replace potassium cautiously, check magnesium and investigate renal wasting; monitor ECG.
- Metabolic acidosis: obtain blood gas, treat shock/sepsis and discuss bicarbonate or dialysis according to severity.
- Hypernatremia/dehydration: replace water gradually and monitor neurological status.
- Phosphate/calcium disturbances: assess tetany, weakness, seizures and ECG changes; correct under local protocol.
Nursing care and monitoring
- Measure urine output accurately, including hourly output when unstable, and document fluid balance and daily weight.
- Monitor BP, ECG, RR, SpOâ‚‚, mental state, temperature, oedema, rash and lung sounds.
- Check medicine doses, renal clearance, interactions and timing; record any suspected adverse reaction.
- Maintain aseptic catheter care, skin protection, nutrition and safe mobility.
- Escalate fever, rash with hypotension, oliguria, hyperkalaemia, breathlessness, confusion, seizure or chest pain.
- Explain investigations, biopsy, dialysis possibility and follow-up using teach-back.
Complications
| Complication | Clues | Response |
|---|---|---|
| AKI/hyperkalaemia | Oliguria, weakness, ECG changes or rising creatinine. | Emergency renal/electrolyte pathway and nephrology review. |
| Fluid overload | Crackles, hypoxia, orthopnoea, oedema and hypertension. | Upright, oxygen/ventilation, fluid review and diuresis/dialysis assessment. |
| Severe electrolyte wasting | Weakness, cramps, arrhythmia, tetany or seizures. | ECG, urgent replacement and repeat levels. |
| Sepsis/immune disease | Fever, hypotension, rash, joint/lung symptoms or shock. | Cultures, antibiotics/source control and specialist therapy. |
| Chronic kidney disease | Persistent creatinine, anaemia, hypertension or proteinuria. | Nephrology follow-up, renal protection and long-term education. |
Prevention and discharge
- Record drug allergies and suspected nephrotoxic reactions clearly; advise the patient to report them everywhere.
- Avoid unsupervised NSAIDs, herbal mixtures and over-the-counter medicines during kidney illness.
- Maintain appropriate hydration, especially during fever, diarrhoea or heat exposure, unless fluid restricted.
- Repeat renal function/electrolytes after discharge and review medicine doses.
- Teach return precautions: reduced urine, swelling, breathlessness, fever/rash, palpitations, severe weakness or confusion.
Clinical scenarios
Scenario 1 – Drug-induced ATIN: A patient develops fever, rash, eosinophilia and rising creatinine two weeks after an antibiotic. Stop the suspected medicine under senior direction, assess sepsis and renal complications, and arrange urgent nephrology review.
Scenario 2 – Tubular injury after shock: A patient recovering from septic shock becomes oliguric with acidosis. Monitor ECG/electrolytes, maintain euvolaemia, avoid nephrotoxins and discuss renal replacement if complications persist.
Scenario 3 – Chronic tubulointerstitial disease: A patient has years of nocturia, polyuria, bland urine and slowly declining eGFR. Arrange renal evaluation, medication/toxin review, electrolyte testing and CKD education.
Common errors to avoid
- Waiting for fever, rash and eosinophilia before considering ATIN.
- Continuing the suspected medicine while awaiting biopsy.
- Giving large fluids to an overloaded patient or withholding fluids from true shock.
- Ignoring electrolyte wasting, polyuria or acid-base disturbance.
- Failing to review herbal remedies, occupational exposures and over-the-counter medicines.
- Discharging without repeat renal tests and specialist follow-up.
TUBULE SAFE: T – Timeline medicines/exposures; U – Urine and output; B – BP/breathing; U – Urgent electrolytes; L – Look for systemic disease; E – Escalate renal failure. S – Stop culprit; A – Assess volume; F – Follow labs; E – Educate.
Revision questions
- What is the difference between glomerular and tubulointerstitial disease?
- List common medicine causes of acute interstitial nephritis.
- Why can the classic fever-rash-eosinophilia triad be absent?
- What tests assess tubular function and dangerous complications?
- When should steroids or renal replacement be considered?
- How do chronic tubulointerstitial diseases present?
- Write a nursing plan for a patient with ATIN and oliguria.
Key takeaways
- Acute tubulointerstitial disease is often reversible when the trigger is removed early.
- Medication reconciliation and urine/creatinine trends are central to diagnosis.
- Manage sepsis, shock, obstruction, electrolyte disorders and fluid overload promptly.
- Do not delay nephrology referral in AKI, systemic disease or suspected ATIN.
- Clear documentation of drug reactions prevents future kidney injury.